Redeye: Ngenic - Continued Growth Strategy

Redeye thinks the Q1 report was another step in the right direction operationally. The company notes continued high demand for its services. We believe Ngenic will continue with its growth strategy as it sees a strong market potential ahead.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source: MFN

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.